Nature doesn't prioritize longevity; it prioritizes continuity.
At Hebrew University, researchers have found in a small fish what evolution has long kept hidden in plain sight: a single gene that grants the gift of vigorous youth while quietly writing the terms of an earlier death. The gene vgll3 accelerates growth and reproduction, then turns those same cellular engines toward cancer and decay — a living demonstration of antagonistic pleiotropy, the theory that nature optimizes for offspring, not longevity. Because this gene exists in humans as well, the discovery invites a profound question: can we one day honor the bargain evolution struck without paying its full price?
- A gene called vgll3 has been caught doing something evolution rarely reveals so clearly — trading a longer life for a faster start, with tumors and early death as the hidden cost.
- CRISPR-edited killifish grew faster and matured sooner than their peers, but also developed melanoma-like cancers and died younger, making the evolutionary trade-off impossible to dismiss.
- The same cellular machinery — cell division, stem cell activity, DNA repair — that builds a thriving young body runs unchecked into old age, accumulating damage until it becomes the engine of disease.
- Because vgll3 is present in humans and already linked to puberty timing and hormone levels, the stakes of this fish study extend far beyond the lab tank.
- Researchers are now racing to determine whether the gene's youthful benefits can be surgically separated from its aging harms — a question that could redefine how medicine approaches cancer and age-related illness.
A research team at Hebrew University has identified a gene that captures one of evolution's most unforgiving compromises: vgll3 accelerates growth and early sexual maturity in youth, but plants the seeds of cancer and premature death in the same stroke. Working with the African turquoise killifish — a short-lived species long used in aging research — the scientists used CRISPR to modify the gene and observed the consequences directly. The edited fish grew faster and matured earlier, advantages that would have served their ancestors well. But they also developed more tumors, including cancers resembling human melanoma, and died sooner. The trade-off was unambiguous.
The finding gives experimental weight to antagonistic pleiotropy, a decades-old theory proposing that genes helpful in early life can become harmful later on. Pinning down the actual genes responsible has long eluded researchers — until now. As the lead scientist framed it, the study catches evolution in the act of choosing reproduction over longevity. The mechanism runs through vgll3's influence on cell division, stem cell behavior, and DNA repair: the same frenetic cellular activity that builds a strong young body accumulates damage over time, and the machinery of growth becomes the machinery of disease.
The significance reaches beyond fish biology. vgll3 exists in humans, where it has already been associated with puberty timing and hormone regulation. The team — which also included collaborators from the Technion and the University of East Anglia — developed a new immunodeficient killifish model as part of the work, enabling tumor transplantation studies not previously possible in the species. Their next focus will be on whether the gene's early benefits can be decoupled from its later harms, a question that could open new paths for preventing and treating the diseases that accompany human aging.
A team of researchers at Hebrew University has identified a gene that embodies one of evolution's cruelest bargains: it turbocharges youth at the cost of a shortened life. The gene, called vgll3, drives rapid growth and early sexual maturity—advantages that would have meant reproductive success in ancestral environments. But the same genetic switch that builds a vigorous young body also seeds the conditions for cancer and premature aging, a finding that provides some of the clearest experimental evidence yet for a theory biologists have debated for decades.
The work centers on the African turquoise killifish, a small fish with a naturally brief lifespan that has become a standard model for aging research. Using CRISPR gene-editing technology, the team altered vgll3 and watched what happened. Fish carrying the modified gene grew faster and reached sexual maturity earlier than their unmodified peers—traits that would confer obvious advantages in the wild. But those same fish developed more age-related tumors, including cancers that resembled melanoma in humans, and they died younger. The trade-off was stark and unmistakable.
This discovery speaks directly to a long-standing puzzle in evolutionary biology called antagonistic pleiotropy—the idea that genes beneficial early in life can become liabilities later on. For decades, researchers have suspected this pattern exists in vertebrates, but pinpointing the actual genes responsible has proven difficult. The vgll3 finding changes that. As Dr. Itamar Harel of Hebrew University put it, the research amounts to catching evolution in the act of making a choice. Nature, he suggested, does not prioritize longevity; it prioritizes reproduction. We are built to sprint, not to endure.
The mechanism behind this trade-off appears to lie in how vgll3 influences fundamental cellular processes. The gene affects cell division, stem cell activity, and DNA repair—the very systems that enable rapid growth and tissue building in youth. Higher levels of cellular activity help explain why the modified fish developed so quickly when young. But that same frenetic cellular machinery, running unchecked over time, accumulates damage. The cells that once built a vigorous body begin to malfunction, and cancer emerges. The machinery of youth becomes the machinery of disease.
What makes this finding particularly significant is that vgll3 is not unique to killifish. The gene exists in humans, and earlier studies have linked it to the timing of puberty and hormone levels. The discovery opens a new avenue for understanding human development, aging, and the diseases that accompany aging. It also raises a tantalizing possibility: if the early-life benefits of vgll3 can be separated from its later harmful effects, researchers might eventually find ways to preserve youthful vigor while extending healthy lifespan.
The team, which included collaborators from the Technion and the University of East Anglia, also developed a new tool in the process—an immunodeficient killifish model that allows researchers to transplant and study tumor cells in ways that were not previously possible in this species. This advance alone may accelerate future cancer research in the model organism. The next phase of the work will focus on whether the gene's youthful benefits can be decoupled from the diseases of aging, a question that could reshape how scientists approach prevention and treatment of age-related illness.
Notable Quotes
We have effectively caught evolution in the act of making a trade-off. Nature doesn't prioritize longevity; it prioritizes continuity. We are built to sprint, not to marathon.— Dr. Itamar Harel, Hebrew University
The cancer we see in these fish isn't a random accident. It's the direct shadow of their youthful vitality. The same machinery that drives a cell to build a young body is hijacking the system to build a tumor in the old one.— Dr. Itamar Harel, Hebrew University
The Hearth Conversation Another angle on the story
So this gene makes fish grow faster and reproduce earlier. That sounds like a pure advantage. Why would evolution keep the downside?
Because in nature, you don't get points for living to ninety. You get points for having children before you die. If vgll3 lets you reach reproductive age faster and have more offspring, that's a win—even if it kills you at five instead of eight.
But surely there's a way to have both—fast growth and a long life?
That's the question everyone wants answered. The problem is that the same cellular machinery that builds a young body fast is the machinery that accumulates damage. Speed and durability are often at odds.
The researchers mention this could apply to humans. Are we walking around with the same trade-off?
We likely are, yes. We have vgll3 too. We grow, we mature, we reproduce—and then we age. The question is whether we can learn to turn off the harmful part without losing the benefits.
Is that even possible?
That's what they're trying to figure out next. If you can separate the two functions, you might be able to keep the growth without the cancer. That's the hope, anyway.